May 28, 2022 at 3:10 pm #130956
I realize that some trans people do self-medicate, for any number of reasons. In my estimation, there are some particular reasons not to.
This passage is significant:
Monitoring for transgender women (MTF) on hormone therapy:
- Monitor for feminizing and adverse effects every 3 months for first year and then every 6– 12 months.
- Monitor serum testosterone and estradiol at follow-up visits with a practical target in the female range (testosterone 30 – 100 ng/dl; E2 <200 pg/ml).
- Monitor prolactin and triglycerides before starting hormones and at follow-up visits.
- Monitor potassium levels if the patient is taking spironolactone.
- BMD screening before starting hormones for patients at risk for osteoporosis. Otherwise, start screening at age 60 or earlier if sex hormone levels are consistently low.
- MTF patients should be screened for breast and prostate cancer appropriately.
It is likely that none of these would happen if self-medicating. I would have to think that monitoring these various things have significance, else why make them a part of the process?